Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Computational platform for modelling, analysis, and prediction of anti-EGFR drug resistance for lung cancer.

Hong Kong medical journal = Xianggang yi xue za zhi - 1 Dec 2019

Yan H, Zhu G Y, Wong M, Lee V

Abstract excerpt

No abstract is available from the source.

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Antineoplastic Agents
Share to Carcinoma, Non-Small-Cell Lung
Share to Computer Simulation
Share to Drug Resistance, Neoplasm

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Share to ErbB Receptors

Share to Lung Neoplasms

Share to Mutation

Source

Identifiers

PMID: 31889035

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 2 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Computational platform for modelling, analysis, and prediction of anti-EGFR drug resistance for lung cancer.PMID 31889035Read ↗

Computational Methods for the Analysis and Prediction of EGFR-Mutated Lung Cancer Drug Resistance: Recent Advances in Drug Design, Challenges and Future Prospects.Semantic proximity Read ↗

Personalized prediction of EGFR mutation-induced drug resistance in lung cancer.Semantic proximity Read ↗

Identification and molecular modelling of potential drugs targeting the genes involved in the progression of lung cancer in patients with idiopathic pulmonary fibrosisSemantic proximity Read ↗

Machine learning based personalized drug response prediction for lung cancer patients.Semantic proximity Read ↗

Genomic and computational-aided integrative drug repositioning strategy for EGFR and ROS1 mutated NSCLC.Semantic proximity Read ↗

The Cancer Cell Line Encyclopedia enables predictive modelling of anticancer drug sensitivitySemantic proximity Read ↗

Mathematical Model of Intrinsic Drug Resistance in Lung Cancer.Semantic proximity Read ↗

Optimizing Cardiovascular Treatment in Non-Small Cell Lung Cancer: A Comprehensive Computational Approach for Assessment of Drug-Drug Interactions Between Tyrosine Kinase Inhibitors and Cardiovascular DrugsSemantic proximity Read ↗

In silico resources help combat cancer drug resistance mediated by target mutations.Semantic proximity Read ↗

Optimizing Cardiovascular Treatment in Non-Small Cell Lung Cancer: A Comprehensive Computational Approach for Assessment of Drug-Drug Interactions between Tyrosine Kinase Inhibitors and Cardiovascular DrugsSemantic proximity Read ↗

Computational Analysis of Epidermal Growth Factor Receptor Mutations Predicts Differential Drug Sensitivity Profiles toward Kinase Inhibitors.Semantic proximity Read ↗

Predicting Personalised Therapeutic Combinations in Non-Small Cell Lung Cancer Using In Silico ModellingSemantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.